GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies for serious neurodevelopmental disorders, today announced that it has dosed the first patient in its global ...

A sweeping new study of psychiatric and genetic records has the potential to change treatment for millions of psychiatric ...

The findings one day could allow people with multiple mental health conditions to be treated with a single therapy, ...

The review looked at more than three dozen studies and found no evidence that acetaminophen increased the risk of ...

Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more individualized care. Adding genetic testing to the evaluation of pediatric ...

A new scientific review finds no evidence that acetaminophen, commonly known as Tylenol, increases the risk of autism or ...

Scientists have found that children who have neurodevelopmental conditions are also more likely to report congenital abnormalities, like heart or urinary tract defects, compared to children without ...